Patent Application
20170240720
This invention relates to a polymer composition comprising a thermoplastic alkyl polymer and an antimicrobial. This invention also relates to products and fabrics incorporating the polymer composition.
It is known to incorporate antimicrobials into consumer products in order to inhibit the growth of, for example, bacteria and/or fungi and/or viruses. However, the selection of a suitable antimicrobial depends significantly on the product into which it is to be incorporated. This invention seeks to provide a polymer composition comprising an antimicrobial which can be utilised in a wide range of products, and in particular which can be made into fibres which can be formed into fabrics. This invention also seeks to provide a polymer composition comprising an antimicrobial which has low toxicity to human and other mammalian cells.
This invention relates to an antimicrobial master batch polymer composition comprising:
In relation to this invention, the term “antimicrobial” is used to refer to a substance that can kill microorganisms or inhibit their growth. Examples of antimicrobials include germicides, antibiotics, antibacterials, antivirals and antifungals. It is preferred that the antimicrobial provides up to a log 4 reduction in the number of cells of the microorganism in question. For example, a reduction in the number of cells from 108 to 104 would be a log 4 reduction (ie killing of 99.9% of the cells in question).
In relation to this invention, the term “master batch” is used to refer to a mixture of ingredients which can be added to a polymer in order to impart a particular property to that polymer (in this invention, antimicrobial activity). The use of a master batch, rather than adding the antibacterial directly to the final polymer composition, can make subsequent processing easier as well as improving the homogeneity of the antimicrobial in the final polymer.
It is preferred that the thermoplastic alkyl polymer is polypropylene, ethylene vinyl acetate or polyethylene, polypropylene being particularly preferred.
Preferably, the antimicrobial is a chlorophenol compound. More preferably, the chlorophenol compound is 4-chloro-3,5-dimethylphenol, 2-chloro-3-methyl-phenol, 2,4-dichloro-3,5-dimethylphenol, 2,4-dichloro-5-methylphenol, 4-chloro-3-methylphenol and/or 2,4,6-trichlorophenol. It has been surprisingly found that these antimicrobials perform especially well in the compositions of the invention. In particular, compared to other antimicrobials they provide improved retention of antimicrobial activity after the heat treatment involved in plastics processing. In some embodiments, 4-chloro-3,5-dimethylphenol is particularly preferred.
Alternative antimicrobials include 2-bromo-2-nitropropane-1,3-diol and quaternary ammonium compounds such as quaternary ammonium alkyl compounds. Examples of quaternary ammonium alkyl compounds include benzalkonium chloride and didecyldimethylammonium chloride
Preferably, the antimicrobial master batch polymer composition comprises 5-35 wt % of the antimicrobial, more preferably 5-15 wt %, even more preferably about 10 wt % of the antimicrobial. In preferred embodiments, the remainder of the antimicrobial master batch polymer composition comprises the thermoplastic alkyl polymer and incidental impurities.
This invention also relates to method of making an antimicrobial master batch polymer composition as described above, comprising the steps of:
The weight ratio of thermoplastic alkyl polymer powder to antimicrobial powder in the mixing step is preferably between 17:3 and 19:1, more preferably about 9:1.
In some embodiments, the composition is extruded after the melting step and before the cooling step. The extrusion step may be carried out using a twin-screw extruder. The extrusion temperature is preferably 140-210° C., more preferably about 180° C.
The cooling step preferably comprises cooling in a water bath. The water bath is preferably at room temperature (for example, around 20-25° C.).
It is preferred that after step (c) the method comprises the step of: (d) forming the mixture into pellets. This can be done, for example, by chopping or crushing. Alternatively, the mixture may be formed into granules.
This invention therefore also relates to a polymer composition comprising:
The thermoplastic alkyl polymer is preferably polypropylene or polyethylene. The thermoplastic alkyl polymer is normally the same as that in the antimicrobial master batch polymer composition. When the thermoplastic alkyl polymer is polypropylene, it is preferably homopolymer polypropylene.
Preferably, the polymer composition comprises 1-20 wt % of the antimicrobial master batch polymer composition, more preferably 1-10 wt %, even more preferably 1-8 wt %. In preferred embodiments, the remainder of the polymer composition comprises the thermoplastic alkyl polymer and incidental impurities.
This invention also relates to method of making a polymer composition as described above, comprising the steps of:
The weight ratio of antimicrobial master batch polymer composition to thermoplastic alkyl polymer powder in the mixing step is preferably between 1:100 and 1:5, more preferably between 1:100 and 1:10, even more preferably between 1:100 and 2:25.
The polymer composition may subsequently be processed as described above in relation to the antimicrobial master batch polymer composition.
This invention also relates to moulded products comprising the polymer composition. Example products include bowls such as pet bowls (dog, cat or horse bowls); waste bins; curtain hooks; lavatory seats; sharps boxes and other moulded products used in the medical field; chopping boards and other moulded products used in food preparation; containers and mats.
This invention also relates to a method of making a fabric comprising the polymer composition described above, the method comprising the steps of:
The forming step may be carried out by extruding the composition through a die at high pressure. The binding step may be carried out by compression, for example using a PTFE belt.
This invention also relates to a fabric comprising the polymer composition as described above. The fabric is preferably a nonwoven fabric (ie one that has not been either woven or knitted) comprising fibres of the polymer composition. The fabric is typically in the form of a sheet or web. In certain applications, it can be advantageous to include the antimicrobial in the polymer from which the fabric is made (as in this invention) rather than spraying the antimicrobial onto the fabric after manufacture. Providing the antimicrobial in the polymer composition can result in (i) a more even distribution of the antimicrobial in the fabric, and (ii) a reduction in the weight added to the fabric (compared to spraying the antimicrobial onto the fabric).
This invention also relates to products comprising the fabric described above. Example products include curtains, such as shower curtains or those used in hospital cubicles; blinds; wheelchair seat covers; pet beds, such as dog or cat beds; or blankets, such as horse blankets.
A polymer composition was formed by mixing polypropylene (PP) powder with 4-chloro-3,5-dimethylphenol (PCMX) powder in a weight ratio of approximately 9:1. The mixture was then passed through a twin-screw extruder at a temperature of around 180° C. The resulting extruded composition was then cooled in a water bath and formed into pellets. These pellets were then mixture with homopolymer polypropylene (HPPL) in the weight amounts described below. The samples were then extruded at 180° C. and formed into sheets.
Three samples were prepared as follows:
The samples were in good visible condition.
70×45 mm panels of each of the samples were surface inoculated with 0.1 ml culture of the test species as detailed in Table 1 below. The inoculum was spread over the surface using a sterile L shaped spreader and the panels stored at room temperature. At 30 minutes after inoculation the panel surfaces were swabbed and washed with sterile Maximum Recovery Diluent containing preservative neutralisers and the number of survivors determined by serial dilution and plate counting. The plates were then incubated at 34° C. to 36° C. for 48 hours.
Pseudomonas aeruginosa, (ATCC 15442)
Escherichia coli, (ATCC 10536)
Staphylococcus aureus, (ATCC 6538)
Enterococcus hirae, (ATCC 10541)
Candida albicans, (ATCC 10231)
Aspergillus brasilliens, (ATCC 16404)
The test results for the mixed bacteria at 30 minutes after inoculation are shown in Table 2 below.
The test results for the mixed fungi at 30 minutes after inoculation are shown in Table 3 below.
These test results indicate that a reduction of greater than 99.9% kill (ie a greater than log 3 reduction) was achieved in a microbial challenge test against a cocktail of bacteria and fungi. Thus, the panels demonstrated a >99.9% reduction in the numbers of bacteria and fungi when the composition was applied to the surface of the plastic panels.
| Number | Date | Country | Kind |
|---|---|---|---|
| 1410514.2 | Jun 2014 | GB | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/GB2015/051615 | 6/3/2015 | WO | 00 |
